Literature DB >> 2410790

Association of platelet-activating factor with primary acquired cold urticaria.

K E Grandel, R S Farr, A A Wanderer, T C Eisenstadt, S I Wasserman.   

Abstract

We investigated the possibility that the inflammatory reaction in primary acquired cold urticaria might be associated with the release of platelet-activating factor. Six patients with the disease and five normal controls were subjected to cold-water challenges during which blood samples were obtained for measurement of the release of possible mediators: i.e., histamine, neutrophilic chemotactic activity, and platelet-activating factor-like lipid (PAF-LL). Four of the patients had pronounced experimentally induced cold urticaria with angioedema and release of mediators. Levels of the three mediators were not elevated in five normal controls or in two patients in whom cold challenges induced only mild urticaria and angioedema. The effective suppression of cold-induced urticaria in three patients treated with doxepin correlated with inhibition of PAF-LL release but not inhibition of histamine or neutrophilic chemotactic activity release. These data suggest a positive correlation between PAF-LL release and cold urticaria, although the exact relation between PAF-LL and cutaneous lesions of primary acquired cold urticaria has not yet been established.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410790     DOI: 10.1056/NEJM198508153130702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

1.  Platelet-activating factor induces proliferation in differentiated keratinocytes.

Authors:  Astrid J Feuerherm; Katarina M Jørgensen; Randi M Sommerfelt; Live E Eidem; Astrid Lægreid; Berit Johansen
Journal:  Mol Cell Biochem       Date:  2013-08-24       Impact factor: 3.396

2.  Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice.

Authors:  L Kemény; V Trach; A Dobozy
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

3.  Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor.

Authors:  N M Ruis; J K Rose; F H Valone
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Modern approaches to the diagnosis and treatment of cold contact urticaria.

Authors:  Karoline Krause; Torsten Zuberbier; Marcus Maurer
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

5.  The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis.

Authors:  A I Mallet; P Norris; N B Rendell; E Wong; M W Greaves
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

6.  Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.

Authors:  Qiwei Zhang; Nico Mousdicas; Qiaofang Yi; Mohammed Al-Hassani; Steven D Billings; Susan M Perkins; Katherine M Howard; Satoshi Ishii; Takao Shimizu; Jeffrey B Travers
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

7.  Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

Authors:  S W Chang; C O Feddersen; P M Henson; N F Voelkel
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

8.  Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking.

Authors:  T Imaizumi
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

9.  Etiological approach to chronic urticaria.

Authors:  D S Krupa Shankar; Mukesh Ramnane; Eliz Aryal Rajouria
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

Review 10.  Leukotriene B4 and platelet-activating factor in human skin.

Authors:  L Michel; L Dubertret
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.